Rituximab for auto-immune alveolar proteinosis, a real life cohort study

Overview of attention for article published in Respiratory Research, April 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 6,845 followers.

RT @RaphaelBorie: Still a interest for retrospective collaborative studies @OrphaLung @bruno_crestani @fratommy75 Rituximab for auto-immune…

RT @RaphaelBorie: Still a interest for retrospective collaborative studies @OrphaLung @bruno_crestani @fratommy75 Rituximab for auto-immune…

RT @RaphaelBorie: Still a interest for retrospective collaborative studies @OrphaLung @bruno_crestani @fratommy75 Rituximab for auto-immune…

Still a interest for retrospective collaborative studies @OrphaLung @bruno_crestani @fratommy75 Rituximab for auto-immune alveolar proteinosis, a real life cohort study https://t.co/p1lCrYQRDM #

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.